HHS - paediatric
Paediatric hyperosmolar state · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Hyperosmolar hyperglycaemic state in children is rare but increasing in obese adolescents with type 2 diabetes, and is managed DIFFERENTLY from paediatric DKA. Features: very high glucose (often >33 mmol/L), osmolality >320 mosmol/kg, with minimal ketosis/acidosis. Here fluid replacement is more generous and insulin is started later and lower than in DKA.
Assessment
Investigations
- Glucose, osmolality (2 x Na + glucose + urea), ketones, VBG
- U&E, phosphate, CK (rhabdomyolysis risk); ECG
- Distinguish from DKA (different fluid/insulin approach); identify precipitant
- Frequent neuro observations
Management
- Fluids are more liberal than in paediatric DKA - restore circulating volume with isotonic (0.9%) saline
- Replace the fluid deficit gradually over 24-48 h, aiming for a slow, controlled fall in osmolality and glucose
- Insulin is started LATER and LOWER than in DKA: begin 0.025-0.05 units/kg/hour ONLY once glucose is no longer falling adequately (about 3 mmol/L/h) with fluids alone
- Avoid rapid shifts in glucose, sodium and osmolality (cerebral oedema risk)
- Replace potassium and phosphate as guided by levels
- Watch for the specific HHS complications: venous thrombosis (consider thromboprophylaxis), rhabdomyolysis, arrhythmia and a malignant-hyperthermia-like presentation
- Frequent monitoring of glucose, electrolytes, osmolality, neuro obs and fluid balance
- Involve PICU and the paediatric diabetes/endocrine team early; treat the precipitant
Drugs & doses
Isotonic (0.9%) saline - more generous rehydration than DKA
Insulin 0.025-0.05 units/kg/h IV (start later, only once glucose plateaus)
Potassium and phosphate replacement (per levels)
Thromboprophylaxis (consider)
Disposition
PICU; paediatric diabetes/endocrine team.
Paediatric HHS is not DKA - give MORE fluid up front and start insulin later and at a lower dose, dropping the osmolality slowly.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.